Decoy Therapeutics is trading 11.45% up now at $2.92 after closing at $2.63 on September 8, 2026, with no clear company-specific catalyst identified.
- The company announced a September 9–10 investor conference appearance, including a September 10 corporate presentation.
- Available coverage does not identify the appearance as a direct catalyst for the after-hours move.
- No earnings release, regulatory decision, financing announcement, or other major company-specific news was found.